Seres Therapeutics Inc.

NASDAQ: MCRB · Real-Time Price · USD
16.39
-1.30 (-7.35%)
At close: Aug 19, 2025, 3:59 PM
16.25
-0.85%
After-hours: Aug 19, 2025, 05:57 PM EDT

Seres Therapeutics Revenue

Seres Therapeutics reported an annual revenue of $0, reflecting a -100% growth. For the quarter ending June 30, 2025, Seres Therapeutics generated $0 in revenue.
Revenue (ttm)
0
Revenue Growth
-100%
Price / Sales Ratio
0
Revenue / Employee
0
Employees
103
Market Cap
143.49M

Revenue Chart

Revenue History

Fiscal Year End Revenue % Change
Dec 31, 2024 0 -100.00%
Dec 31, 2023 126.33M +1672.24%
Dec 31, 2022 7.13M -95.08%
Dec 31, 2021 144.93M +336.33%
Dec 31, 2020 33.22M -3.74%
Dec 31, 2019 34.51M +22.07%
Dec 31, 2018 28.27M -11.94%
Dec 31, 2017 32.1M +47.48%
Dec 31, 2016 21.77M +Infinity%
Dec 31, 2015 0 n/a
Dec 31, 2014 0 n/a
Dec 31, 2013 0 n/a
Dec 31, 2012 0 n/a
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.